Fresenius Medical completes change of legal form from a partnership into a German stock corporation
- Co announces the successful completion of its change of legal form from a partnership limited by shares into a German stock corporation (Aktiengesellschaft, AG) as of November 30, 2023.
- With this important milestone, Fresenius Medical Care is opening a new chapter in the history of the Company with a simplified corporate governance structure that gives the Company more flexibility and autonomy.
- The role of the free float shareholders is also strengthened.
- As the largest shareholder with approx. 32.2 percent of the ordinary share capital, Fresenius SE & Co. KGaA (Fresenius) has appointed its CEO Michael Sen and its CFO Sara Hennicken as members of the new Supervisory Board -- with Michael Sen serving as Chair.